Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[thefamilyman]

@NJ - Over the last three weeks I have done several hours of online research on both pancreatic and prostate cancers. There is a significant amount of research detailing the role of NFkB in those diseases. Several studies for both cancers identified the NFkB pathway as a possible target for future treatment options.

I even looked up email addresses for two of the researchers who were both involved in two of the studies. In the email I pointed out the NFkB connection in the only two peer reviewed studies of anatabine that have been completed to date. I also included a link to the Johns Hopkins study. That was two weeks ago and of course I have not received a response. However, they work at a university based facility and I know from experience that most such faculty are often off campus until sometime in August. We shall see...